Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach

Abstract

First-degree relatives (FDRs) and spouses to a population-derived cohort of lupus patients were investigated for the occurrence of selected autoantibodies and self-reported health complaints. A healthy reference population was included. The lupus population consisted of 103 index cases. A total of 275/375 available relatives accepted to enter the study. Two hundred and twenty-six/315 (72%) were FDRs and 49/60 (82%) were spouses. Serum was analysed for ANA using indirect immunofluorescence on Hep-2 cells at the following dilutions: 1: 40, 1: 80 and 1: 160 and in addition sera were tested for anti-dsDNA, IgM RF, ACA (IgM, IgG), anti-β₂ GPI (IgM, IgG) and antibodies to prothrombin. ANA positivity occurred more frequently in FDRs compared with spouses and controls at serum dilution 1: 160 (10 versus 0% and 2.5%, respectively, P = 0.04 and P < 0.01), 1: 80 (24 versus 4% and 5%, respectively, P = 0.003 and P < 0.001) and 1: 40 (31 versus 10% and 10%, respectively, P = 0.006 and P < 0.0001). ANA positivity in FDRs occurred randomly, irrespective of family relationship. Fifty-three/184 versus 2/32 FDRs to patients with definite SLE (D-SLE) and incomplete SLE (I-SLE), respectively, tested ANA positive at 1: 80 (P < 0.05). FDRs with ANA titer at 80 were affiliated to lupus probands with high SLICC scores (P < 0.05). Self-reported health complaints, cardiovascular/thromboembolic events in particular, were more frequent among FDRs than in spouses. The population-based approach adopted in the present study supports previous clinic-based evidence of an increased propensity for autoantibody occurrence in relatives to SLE patients. In FDRs, present ANA positivity was associated with increased prevalence of health complaints and ANA positivity in FDRs was related to the criterial burden and cumulated damage in corresponding lupus probands. The low ANA frequency among spouses of SLE patients argues against a significant autoantibody triggering effect of shared environment in adult life.

Keywords

antinuclear antibodies family studies systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Marrack P , Kappler J , Kotzin BL. Autoimmune disease: why and where it occurs . Nat Med 2001; 7: 899-905 .

Tsao BP. An update on genetic studies of systemic lupus erythematosus . Curr Rheumatol Rep 2002; 4: 359-367 .

Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus . J Rheumatol 1987; 14: 867-869 .

Lawrence JS , Martins CL , Drake GL. A family survey of lupus erythematosus. 1. Heritability . J Rheumatol 1987; 14: 913-921 .

Grennan DM , Parfitt A , Manolios N et al. Family and twin studies in systemic lupus erythematosus . Dis Markers 1997; 13: 93-98 .

Levy M , Molta C , Meyer O et al. Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study . Contrib Nephrol 1992; 99: 26-34 .

Takei S , Maeno N , Shigemori M et al. Clinical features of Japanese children and adolescents with systemic lupus erythematosus: results of 1980-1994 survey . Acta Paediatr Jpn 1997; 39: 250-256 .

Michel M , Johanet C , Meyer O et al. Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families . Medicine (Baltimore) 2001; 80: 153-158 .

Mohan C. Murine lupus genetics: lessons learned . Curr Opin Rheumatol 2001; 13: 352-360 .

10.

Napirei M , Karsunky H , Zevnik B , Stephan H , Mannherz HG , Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice . Nat Genet 2000; 25: 177-181 .

11.

Bickerstaff MC , Botto M , Hutchinson WL A et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity . Nat Med 1999; 5: 694-697 .

12.

Prokunina L , Castillejo-Lopez C , Oberg F et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans . Nat Genet 2002; 32: 666-669 .

13.

Pollak VE , Mandema E , Kark RM. Antinuclear factors in the serum of relatives with systemic lupus erythematosus . Lancet 1960; 2: 1061-1063 .

14.

Pollak VE. Antinuclear antibodies in families of patients with SLE . N Engl J Med 1964; 271: 165-171 .

15.

Leonhardt ETG. Family studies in systemic lupus erythematosus . Acta Med Scand Suppl 1964; 176 (Suppl 416): 1-56 .

16.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

17.

Voss A , Green A , Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort . Scand J Rheumatol 1998; 27: 98-105 .

18.

Hook EB , Regal RR. Capture-recapture methods in epidemiology: methods and limitations . Epidemiol Rev 1995; 17: 243-264 .

19.

Barr SG , Zonana-Nacach A , Magder LS , Petri M. Patterns of disease activity in systemic lupus erythematosus . Arthritis Rheum 1999; 42: 2682-2688 .

20.

Gladman DD , Urowitz MB , Goldsmith CH et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 809-813 .

21.

Gladman D , Ginzler E , Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus . Arthritis Rheum 1996; 39: 363-369 .

22.

Chou CT , Pei L , Chang DM , Lee CF , Schumacher HR , Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences . J Rheumatol 1994; 21: 302-306 .

23.

van Venrooij WJ , Main R. Detection of antinuclear antibodies by immunofluorescence. In van Venrooij WJ , Main B eds. Manual of biogical markers of disease A2. Dordrect, the Netherlands: Kluwer Academic , 1993: 1-16.

24.

Tan EM , Feltkamp TE , Smolen JS et al. Range of antinuclear antibodies in ‘healthy’ individuals . Arthritis Rheum 1997; 40: 1601-1611 .

25.

Mouritsen S , Hoier-Madsen M , Wiik A , Orum O , Strandberg PN. The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus . Clin Exp Immunol 1989; 76: 178-183 .

26.

Zouali M. B cell diversity and longevity in systemic autoimmunity . Mol Immunol 2002; 38: 895-901 .

27.

Loizou S , McCrea JD , Rudge AC , Reynolds R , Boyle CC , Harris EN. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results . Clin Exp Immunol 1985; 62: 738-745 .

28.

Voss A , Jacobsen S , Heegaard NH. Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia . Lupus 2001; 10: 533-538 .

29.

Puurunen M , Manttari M , Manninen V , Palosuo T , Vaarala O. Antibodies to prothrombin crossreact with plasminogen in patients developing myocardial infarction . Br J Haematol 1998; 100: 374-379 .

30.

Hoier-Madsen M , Nielsen LP , Moller S. Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA) . Ugeskr Laeger 1986; 148: 2018-2021 .

31.

Altman D. G. Measurement in medicine: the analysis of method comparison studies . Statistican 1990; 32: 307-317 .

32.

Brinck B. Muskel og skeletsygdom I Danmark (Survey from National Institute of Public Health). DIKE, Gentofte, Denmark , 1995.

33.

Mackworth-Young C , Chan J , Harris N et al. High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus . J Rheumatol 1987; 14: 723-726 .

34.

Sato EI , Atra E , Gabriel A Jr , Masi AT. Systemic lupus erythematosus: a family study of 25 probands . Clin Exp Rheumatol 1991; 9: 455-461 .

35.

Dudeney C , Shoenfeld Y , Rauch J et al. A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members . Ann Rheum Dis 1986; 45: 502-507 .

36.

Clark J , Bourne T , Salaman MR , Seifert MH , Isenberg DA. B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus . J Autoimmun 1996; 9: 59-65 .

37.

Du Clos TW. C-reactive protein as a regulator of autoimmunity and inflammation . Arthritis Rheum 2003; 48: 1475-1477 .

38.

Sorensen IJ , Holm NE , Schroder L , Voss A , Horvath L , Svehag SE. Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients . J Clin Immunol 2000; 20: 408-415 .

39.

Grainger DJ , Bethell HW. High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis . Ann Rheum Dis 2002; 61: 110-114 .

40.

Lea RD , Etheredge GD , Freeman JN , Lloyd WB. Familial disability patterns in individuals with chronic work-related spine injury/illness . Spine 2003; 28: 2292-2297 .